Cheng Deng

Title: Innovations by Cheng Deng in Hematology

Introduction

Cheng Deng is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of hematology, particularly through his innovative patents. With a total of 2 patents, his work focuses on improving blood analysis techniques.

Latest Patents

Cheng Deng's latest patents include the preparation and use of nucleated red blood cell simulating particles and hematology control mixtures. This invention provides a nucleated red blood cell simulating particle, which may consist of leukocytes bound to a fluorescent-staining inhibitor. This inhibitor is capable of stably binding to the nucleus or a nucleic acid in a cell, thereby reducing the binding capacity of the particles to a fluorescent dye during detection. The method for preparing these particles involves several steps: obtaining purified leukocytes, suspending them in a cell treatment solution containing the fluorescent-staining inhibitor, and washing the obtained product. Additionally, the patent describes a hematology control mixture containing these nucleated red blood cell simulating particles, which can be used for quality control of blood cell analyzers.

Career Highlights

Cheng Deng is currently associated with Shenzhen Mindray Bio-medical Electronics Co., Ltd. His work at this company has allowed him to focus on developing advanced medical technologies that enhance the accuracy and reliability of blood analysis.

Collaborations

Cheng has collaborated with notable coworkers such as Zuyue Xu and He Liu, contributing to the advancement of their shared projects in the biomedical field.

Conclusion

Cheng Deng's innovative work in hematology demonstrates his commitment to improving medical technology. His patents reflect a significant advancement in the quality control of blood analysis, showcasing the importance of innovation in healthcare.